Obefazimod
Appearance
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H10ClF3N2O |
Molar mass | 338.71 g·mol−1 |
3D model (JSmol) | |
| |
|
Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis.[1] It is miR-124 micro RNA upregulator.[2]
References
[edit]- ^ "Obefazimod - Abivax". AdisInsight. Springer Nature Switzerland AG.
- ^ Datta N, Johnson C, Kao D, Gurnani P, Alexander C, Polytarchou C, et al. (August 2023). "MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis". Pharmacological Research. 194: 106870. doi:10.1016/j.phrs.2023.106870. PMID 37499702.